Varian Medical Systems, Inc. (VAR)

PauvrePapillon (99.79) Submitted: 10/19/07 1:02 PM : Start Price: $42.46 VAR Score: -66.87

Varian may have current market share but their technology has been rendered obsolete by the commercial introduction of Accuray's CyberKnife. This is why Varian's sales have flattened out. Even Varian's hack analyst Amit Hazan admits as much in his la...

Report this Post Replies: 14 | Reply | Permalink

TMFHelical (99.30) Submitted: 1/12/07 8:09 AM : Start Price: $48.20 VAR Score: 39.90

Leader in oncology equipment i.e. directed radiation treatment. Expensive equipment, but constant innovation should continue to drive future growth. Demographics favor expanded health care coverage as well.

Medical diagnostics (early detection) co...

Report this Post Replies: 2 | Reply | Permalink

mkeszler (99.70) Submitted: 7/11/07 1:04 PM : Start Price: $44.31 VAR Score: 57.59

With the aging of the population and longer life expectancy, cancer and it's treatment will continue to be a growth industry. Trust me, I'm a doctor....(ha ha) But seriously, these guys are leaders in their field, make more sophisticated devices to b...

Report this Post Replies: 1 | Reply | Permalink

NetscribeMedDevs (98.63) Submitted: 3/08/07 7:06 AM : Start Price: $45.60 VAR Score: 46.87

Varian Medical Systems is engaged in manufacturing and selling of integrated cancer therapy systems worldwide. Under its Oncology Systems segment, it designs, manufactures, sells and services hardware and software products for treating cancer with ra...

Report this Post Replies: 1 | Reply | Permalink

LuvtoRead (33.10) Submitted: 1/26/07 12:10 PM : Start Price: $45.63 VAR Score: 47.70

Good and solid balance sheet. Continuously making money. Continuously developing their products. Good demographic play. Excellent for long term holding.

Report this Post Replies: 0 | Reply | Permalink

Manifest (84.84) Submitted: 5/31/07 12:39 PM : Start Price: $40.08 VAR Score: 73.78

Varian reported slightly weaker results and moderated expectations going forward and the price got fried. This cancer-treatment supplier isn't slowing a great deal from 15% annualized top line growth -- just a smidge. S&P rates VAR at 91% of fair v...

Report this Post Replies: 0 | Reply | Permalink

james3177 (93.96) Submitted: 10/01/06 9:32 PM : Start Price: $53.21 VAR Score: 22.24

earnings momentum

Report this Post Replies: 0 | Reply | Permalink

DonDP (< 20) Submitted: 1/27/07 1:39 PM : Start Price: $46.07 VAR Score: 46.52

New cancer fighting equipment soon to be released.

Report this Post Replies: 0 | Reply | Permalink

hybridinvestor (36.51) Submitted: 1/25/07 9:11 AM : Start Price: $46.00 VAR Score: 47.77

The leader is cancer therapy and radiation planning systems which had a good report but not good enough for some folks so I am buying the pullback. First nibble at $46.25 on the drop this morning premarket. Will buy more about every 5%-7.5% or so.

Report this Post Replies: 1 | Reply | Permalink

cyncoot (72.45) Submitted: 7/26/08 12:57 PM : Start Price: $58.70 VAR Score: 4.98

Great top and bottom line growth. Excellent profits.

Report this Post Replies: 0 | Reply | Permalink